Mannitol Injection Shortage
Last Updated: March 3, 2025
Status: Current
Products Affected - Description
-
- Osmitrol injection, Baxter, 100 mg/mL, 500 mL premixed bag, 24 count, NDC 00338-0353-03
- Osmitrol injection, Baxter, 200 mg/mL, 500 mL premixed bag, 24 count, NDC 00338-0357-03
- Mannitol injection, BBraun, 200 mg/mL, 500 mL premixed bag, 1 count, NDC 00264-7578-10
- Mannitol injection, ICU Medical, 200 mg/mL, 250 mL premixed bag, 24 count, NDC 00990-7715-02
- Mannitol injection, ICU Medical, 200 mg/mL, 500 mL premixed bag, 12 count, NDC 00990-7715-03
Reason for the Shortage
-
- Baxter has sustained damage to their North Cove plant that supplies large volume fluids.
Available Products
-
- Mannitol injection, Fresenius Kabi, 250 mg/mL, 50 mL vial, 25 count, NDC 63323-0024-25
- Mannitol injection, Pfizer, 250 mg/mL, 50 mL vial, 25 count, NDC 00409-4031-01
Estimated Resupply Dates
-
- All premixed presentations are on allocation.
Alternative Agents & Management
-
- See ASHP Suggestions for Management and Conservation during Fluid Shortages at https://www.ashp.org/drug-shortages/shortage-resources/publications/fluid-shortages-suggestions-for-management-and-conservation
Updated
Updated March 3, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 9, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.